Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Donegal (DGICA) Cash & Equivalents (2016 - 2025)

Donegal (DGICA) has disclosed Cash & Equivalents for 16 consecutive years, with $26.8 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 49.39% to $26.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 million through Dec 2025, down 49.39% year-over-year, with the annual reading at $26.8 million for FY2025, 49.39% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $26.8 million at Donegal, down from $38.6 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $102.4 million in Q1 2021, with the low at $19.8 million in Q1 2024.
  • Average Cash & Equivalents over 5 years is $42.7 million, with a median of $27.7 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents crashed 75.22% in 2022, then soared 224.74% in 2025.
  • Over 5 years, Cash & Equivalents stood at $57.7 million in 2021, then plummeted by 56.47% to $25.1 million in 2022, then decreased by 5.3% to $23.8 million in 2023, then soared by 122.45% to $52.9 million in 2024, then crashed by 49.39% to $26.8 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $26.8 million, $38.6 million, and $57.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.